Skip to content
Politically.com Search all
Menu

2025 · 1st Quarter (Jan 1 - Mar 31)

T1INTERNATIONAL USA

Filed by T1INTERNATIONAL USA.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 8, 2025
Income
Not reported
Expenses
Not reported
Filing UUID
92b65e33-4aa9-441c-be76-12467ae25778
Termination date
Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to the following bills: S. 1040, regarding product hopping; S. 1041, regarding patent evergreening; S. 1095, the Stop STALLING Act; S. 1096, the Preserve Access to Affordable Generics and Biosimilars Act; and a to-be-introduced bill on insulin copays in line with The INSULIN Act of 2023 (S. 1269) and Affordable Insulin Now Act of 2023 (S. 954)

Literal federal measure citations: S. 1040, S. 1041, S. 1095, S. 1096, S. 1269, S. 954

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.